Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zura Bio ( (ZURA) ) has issued an update.
On December 11, 2025, Arnout Ploos van Amstel resigned from Zura Bio Limited’s Board of Directors, effective immediately. His departure also includes resignation from the Nominating and Governance Committee of the Board and was not due to any disagreement regarding the company’s operations, policies, or practices. This change is likely to prompt adjustments in the company’s governance structure, given the loss of contribution from a key board member.
The most recent analyst rating on (ZURA) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Zura Bio stock, see the ZURA Stock Forecast page.
Spark’s Take on ZURA Stock
According to Spark, TipRanks’ AI Analyst, ZURA is a Neutral.
Zura Bio’s overall stock score is driven by significant financial challenges, including no revenue generation and consistent losses despite a strong cash position and no debt. While technical indicators suggest some short-term bullish trends, the negative P/E ratio and lack of dividends underscore the valuation concerns. The company’s ability to generate revenue and improve operational efficiency will be crucial for future performance.
To see Spark’s full report on ZURA stock, click here.
More about Zura Bio
Average Trading Volume: 1,679,195
Technical Sentiment Signal: Buy
Current Market Cap: $267.9M
See more data about ZURA stock on TipRanks’ Stock Analysis page.